Related references
Note: Only part of the references are listed.Current Concepts and Management of Glioblastoma
Matthias Preusser et al.
ANNALS OF NEUROLOGY (2011)
Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment
P. C. Huszthy et al.
GENE THERAPY (2010)
Mathematical Modeling of Herpes Simplex Virus Distribution in Solid Tumors: Implications for Cancer Gene Therapy
Wilson Mok et al.
CLINICAL CANCER RESEARCH (2009)
RADIOSENSITIZING EFFECTS OF TEMOZOLOMIDE OBSERVED IN VIVO ONLY IN A SUBSET OF O6-METHYLGUANINE-DNA METHYLTRANSFERASE METHYLATED GLIOBLASTOMA MULTIFORME XENOGRAFTS
Brett L. Carlson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Hypoxia Enhances the Replication of Oncolytic Herpes Simplex Virus
Manish K. Aghi et al.
MOLECULAR THERAPY (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
Oncolytic Viral Therapy of Malignant Glioma
Jacqueline Nuss Parker et al.
NEUROTHERAPEUTICS (2009)
Oncolytic herpes simplex virus type-1 therapy in a highly infiltrative animal model of human glioblastoma
Peter C. Huszthy et al.
CLINICAL CANCER RESEARCH (2008)
Armed oncolytic herpes simplex viruses for brain tumor therapy
Tomoki Todo
CELL ADHESION & MIGRATION (2008)
Herpes simplex virus Us3(-) mutant as oncolytic strategy and synergizes with phosphatidylinositol 3-kinase-akt-targeting molecular therapeutics
Ta-Chiang Liu et al.
CLINICAL CANCER RESEARCH (2007)
Interleukin-12: Biological properties and clinical application
Michele Del Vecchio et al.
CLINICAL CANCER RESEARCH (2007)
Serial passage through human glioma xenografts selects for a Δγ134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors
Amish C. Shah et al.
JOURNAL OF VIROLOGY (2006)
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response
JN Sarkaria et al.
CLINICAL CANCER RESEARCH (2006)
Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication
M Aghi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro
SL Williams-Aziz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model
EK Hellums et al.
NEURO-ONCOLOGY (2005)
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
C Giannini et al.
NEURO-ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12
RJ Wong et al.
CLINICAL CANCER RESEARCH (2004)
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival
S Harrow et al.
GENE THERAPY (2004)
Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials
RT Sarisky et al.
ARCHIVES OF VIROLOGY (2003)
Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas
AC Shah et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study
V Papanastassiou et al.
GENE THERAPY (2002)
Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in Aotus
T Todo et al.
MOLECULAR THERAPY (2000)
Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors
T Todo et al.
CANCER GENE THERAPY (2000)
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
R Rampling et al.
GENE THERAPY (2000)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
JN Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
